Verve Therapeutics Inc (VERV)

May 09, 2025

Verve Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationVERV - ACCESS Newswire

May 09, 2025

May 08, 2025

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

May 08, 2025

May 07, 2025

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst - Benzinga

May 07, 2025

May 06, 2025

Verve Therapeutics’ SWOT analysis: gene-editing stock shows promise amid challenges - Investing.com

May 06, 2025

May 03, 2025

VERV LAWSUIT ALERT: Levi & Korsinsky Notifies Verve Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

May 03, 2025

May 02, 2025

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 02, 2025

May 02, 2025

Verve Therapeutics Expands Team: 7 New Hires Receive Major Equity Package Worth $1.1M - Stock Titan

May 02, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street - Yahoo Finance

Apr 29, 2025

Apr 26, 2025

Did Verve Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate– VERV - ACCESS Newswire

Apr 26, 2025

Apr 25, 2025

Investors who lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class ActionVERV - ACCESS Newswire

Apr 25, 2025

Apr 21, 2025

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 21, 2025

Apr 18, 2025

Why Verve Therapeutics Zoomed 40% Higher This Week - MSN

Apr 18, 2025

Apr 16, 2025

VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study - MSN

Apr 16, 2025

Apr 16, 2025

Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

Verve Therapeutics: FDA Fast Track And Eli Lilly Partnership Upgrade It To A 'Buy' - Seeking Alpha

Apr 16, 2025

Apr 16, 2025

Verve Therapeutics (VERV) Stock Soars on Positive Trial Results - GuruFocus

Apr 16, 2025

Apr 16, 2025

Cantor Fitzgerald Upgrades Verve Therapeutics (VERV) - MSN

Apr 16, 2025

Apr 15, 2025

Verve impresses investors with second shot at PCSK9 - BioCentury

Apr 15, 2025